| Issue |
E3S Web Conf.
Volume 556, 2024
International Conference on Recent Advances in Waste Minimization & Utilization-2024 (RAWMU-2024)
|
|
|---|---|---|
| Article Number | 01052 | |
| Number of page(s) | 24 | |
| DOI | https://doi.org/10.1051/e3sconf/202455601052 | |
| Published online | 09 August 2024 | |
Thiazolidine derivatives and their pharmacological actions
1 Delhi Transport Corporation, New Delhi, India 144411
2 School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi GT-Road, Phagwara, Punjab 144411
* Corresponding author Email: sanjeev.24026@lpu.co.in
Heterocyclic compounds are the backbone of medicinal chemistry as they gave a prominent number of drugs in the clinical market. Thiazolidine, a five membered heterocyclic compound, possess multiple pharmacological activities viz. anti-microbial, anti-diabetic, anti-cancer, anti-inflammatory, analgesic, anti-convulsant and anti-HIV. Various derivatives of thiazolidine nucleus have been synthesized and screened for these pharmacological activities. The present review summarizes some of these studies that have been reported in the last two decades.
Key words: Heterocyclic compounds / Thiazolidine derivatives / Biological activity
© The Authors, published by EDP Sciences, 2024
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.